Article Text


Basic science (liver)
PMO-114 Low CD39 expression marks severe regulatory t cell impairment in patients with autoimmune sclerosing cholangitis
  1. C R Grant1,
  2. R Liberal1,2,
  3. B Holder1,
  4. Y Ma1,
  5. G Mieli-Vergani1,
  6. D Vergani1,
  7. M S Longhi1
  1. 1Institute of Liver Studies, King's College London, London, UK
  2. 2Faculdade de Medicina da Universidade do Porto, Porto, Portugal


Introduction Autoimmune hepatitis (AIH)/sclerosing cholangitis overlap syndrome (autoimmune sclerosing cholangitis, AISC) is a severe hepatopathy that, in addition to the serological and histological features typical of AIH (hyper γ globulinaemia, autoantibody seropositivity and interface hepatitis), presents with bile duct abnormalities. Both conditions are associated with numerical and functional impairment of CD4+CD25high regulatory T cells (Tregs), a lymphocyte subset central to immune-tolerance. It remains unclear whether the two conditions can be distinguished on the basis of specific immune-regulatory T cell defects. To this end, we have explored a subset of Tregs expressing CD39, an ectoenzyme that contributes to Treg suppression by hydrolysing pro-inflammatory nucleotides and whose polymorphisms are associated with autoimmune disease in humans.

Methods We studied 10 patients with AISC (2 females, median age: 14.5 years), 24 with AIH type 1 (12 females, median age: 16 years) and 25 healthy subjects (HS; 15 females, median age 36 years). The frequency and phenotype of circulating CD4+CD39+CD25high cells (CD39+Tregs) was assessed by flow cytometry using monoclonal antibodies to CD4, CD25, CD39, CD127 and FOXP3. The frequency of IFNγ, IL17 and TGFß-producing CD39+Tregs was determined by intracellular cytokine staining.

Results The frequency of CD39+Tregs was markedly reduced in AISC (0.31±0.11) compared to AIH (4.30±0.89, p<0.01) and HS (7.02±1.28, p<0.01). AISC patients also had fewer CD39+FOXP3+Tregs (0.03±0.02) and CD39+CD127Tregs (0.05±0.02) than AIH patients (FOXP3+: 0.14±0.03, p=0.05; CD127: 0.42±0.10, p<0.01) and HS (FOXP3+: 0.20±0.04, p=0.03; CD127: 0.49±0.07, p=0.01). Analysis of cytokine profiles showed that in AISC there was a higher frequency of CD39+Tregs producing IFNγ (0.23±0.15) and IL17 (0.22±0.14) and a lower frequency of CD39+Tregs producing TGFß (0±0) than in AIH (IFNγ: 0.04±0.02, p=0.05; IL17: 0.03±0.01, p=0.03; TGFß: 0.03±0.01, p=0.09) and HS (IFNγ: 0.07±0.03 p=0.13; IL17: 0.06±0.03, p=0.11; TGFß: 0.02±0.01, p=NS).

Conclusion Compared to AIH and health, CD39+Tregs in AISC are reduced in frequency and display a more proinflammatory cytokine profile. These findings suggest that immune-regulation impairment is more severe in AISC than AIH and implicate CD39 as a marker to differentiate immune-regulatory T-cell defects in the two conditions.

Competing interests None declared.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.